Financial Performance - The company's revenue for Q1 2024 was ¥2,180,464,759.55, representing a 12.52% increase compared to ¥1,937,787,670.11 in the same period last year[5] - Net profit attributable to shareholders decreased by 29.76% to ¥7,046,896.18 from ¥10,032,938.44 year-on-year[5] - Net profit for Q1 2024 was ¥7,263,074.61, a decrease of 29.0% from ¥10,263,465.80 in Q1 2023[16] - Basic earnings per share decreased to ¥0.01 from ¥0.02, reflecting a decline of 50.0% year-over-year[17] Cash Flow - The net cash flow from operating activities improved significantly, reaching ¥5,042,775.40, a 136.62% increase from a negative cash flow of ¥13,769,371.14 in the previous year[8] - The company reported a net cash flow from operating activities of ¥5,042,775.40, recovering from a negative cash flow of ¥13,769,371.14 in the same quarter last year[18] - The net cash flow from investment activities was -67,167,888.32 CNY, compared to a positive cash flow of 23,118,136.33 CNY in the previous period[19] - The total cash inflow from financing activities was 359,902,261.85 CNY, while the cash outflow was 323,142,497.96 CNY, resulting in a net cash flow of 36,759,763.89 CNY[19] - The company experienced a decrease in cash and cash equivalents of 25,170,676.91 CNY during the quarter[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,676,906,903.31, a decrease of 1.93% from ¥4,769,003,949.47 at the end of the previous year[5] - The company's equity attributable to shareholders decreased by 2.91% to ¥2,279,589,712.61 from ¥2,347,994,128.17[5] - Total liabilities decreased slightly to ¥2,391,027,932.72 from ¥2,414,947,856.79, indicating a reduction of 1.0%[16] - Current liabilities total 2,033,891,339.67 CNY, a decrease from 2,069,737,441.43 CNY[12] Investments and Expenses - Research and development expenses surged by 108.75% to ¥27,256,625.41, up from ¥13,057,237.98 in the prior year, indicating increased investment in innovation[8] - Research and development expenses increased significantly to ¥27,256,625.41, compared to ¥13,057,237.98 in the previous year, marking a rise of 108.5%[15] - The company made a new investment of ¥235,805,220.42 in long-term equity, reflecting a 35.17% increase from the previous period[7] - The company experienced a significant increase in tax expenses, which rose to ¥1,657,998.89 from ¥518,340.05, an increase of 220.5%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 102,133[10] - The largest shareholder, Huang Shaoqun, holds 12.73% of shares, amounting to 74,500,000 shares, with 20,500,000 shares pledged and 7,760,000 shares frozen[10] Other Information - The company has not reported any significant new strategies or product developments in the current quarter[11] - The report was issued by the legal representative Huang Shaoqun on April 25, 2024[20]
西陇科学(002584) - 2024 Q1 - 季度财报